Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 2585 Official Publication of Indian Association of Medical Microbiologists 
  Search
 
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~Related articles
 ~  Article in PDF (419 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
 ~  Abstract
 ~ Introduction
 ~  Materials and Me...
 ~ Results
 ~ Discussion
 ~  References
 ~  Article Tables

 Article Access Statistics
    Viewed128    
    Printed5    
    Emailed0    
    PDF Downloaded12    
    Comments [Add]    

Recommend this journal

 


 
  Table of Contents  
ORIGINAL ARTICLE
Year : 2020  |  Volume : 38  |  Issue : 1  |  Page : 94-100
 

Association of toll-like receptors 2, 4, 9 and 10 genes polymorphisms and Helicobacter pylori-related gastric diseases in Saudi patients


1 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia; Department of Medical Microbiology and Immunology, Faculty of Medicine, Menoufia University, Menoufia, Cairo, Egypt
2 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia; Department of Molecular and Clinical Parasitology, National Liver Institute, Menoufia University, Menoufia, Cairo, Egypt
3 Department of Medical Microbiology and Immunology, Faculty of Pharmacy, Taif University, Taif, Saudi Arabia; Department of Clinical Pathology, Faculty of Medicine, Menoufia University, Menoufia, Cairo, Egypt
4 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia
5 Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia; Department of Parasitology, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
6 Department of Public Health and Community Medicine, Faculty of Medicine, Menoufia University, Menoufia, Cairo, Egypt
7 Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Date of Submission18-Apr-2020
Date of Decision23-May-2020
Date of Acceptance03-Jun-2020
Date of Web Publication25-Jul-2020

Correspondence Address:
Dr. Emad M Eed
College of Applied Medical Sciences, King Abdulaziz Campus, Taif

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijmm.IJMM_20_164

Rights and Permissions

 ~ Abstract 


Purpose: Helicobacter pylori is one of the most prevalent human pathogens worldwide. However, the outcomes of H. pylori infection are markedly variable from asymptomatic mild lesion to malignant transformation. Many factors are suggested to influence these infection outcomes, including host immunity and genetic susceptibility. Toll-like receptors (TLRs) can recognise different microbial components and play an essential role in the mucosal immune response against H. pylori infection. Materials and Methods: The association between the common single nucleotide polymorphisms (SNPs) in the genes of TLR2, 4, 9 and 10 and H. pylori-related gastric diseases were investigated by molecular methods after the confirmation of H. pylori infection. The study included 210 patients in three groups; chronic gastritis (n = 90), peptic ulcer disease (PUD) (n = 75) and gastric carcinoma (n = 45). Results: The results showed a significant association between TLR4 SNPs (rs 4986790 and rs 4986791) and the presence of H. pylori infection, especially in chronic gastritis patient group. Furthermore, TLR9-rs352140 TT genotype was more prevalent among chronic gastritis patient group. TLR10-rs 10004195 TT genotype was found to be less prevalent among H. pylori-related chronic gastritis and PUD and was suspected to have a protective effect. TLR2 SNPs (rs3804099 and rs3804100) showed no significant statistical difference between H. pylori-infected patients and the controls. Conclusion: TLR genes polymorphisms may play a role in H. pylori infection susceptibility and may influence its outcomes; however, the ethnic and other factors may modify this effect.


Keywords: Genes, Helicobacter pylori, polymorphisms, Saudi patients, toll-like receptors


How to cite this article:
Eed EM, Hawash YA, Khalifa AS, Alsharif KF, Alghamdi SA, Almalki AA, Almehmadi MM, Ismail KA, Taha AA, Saber T. Association of toll-like receptors 2, 4, 9 and 10 genes polymorphisms and Helicobacter pylori-related gastric diseases in Saudi patients. Indian J Med Microbiol 2020;38:94-100

How to cite this URL:
Eed EM, Hawash YA, Khalifa AS, Alsharif KF, Alghamdi SA, Almalki AA, Almehmadi MM, Ismail KA, Taha AA, Saber T. Association of toll-like receptors 2, 4, 9 and 10 genes polymorphisms and Helicobacter pylori-related gastric diseases in Saudi patients. Indian J Med Microbiol [serial online] 2020 [cited 2020 Aug 11];38:94-100. Available from: http://www.ijmm.org/text.asp?2020/38/1/94/290687





 ~ Introduction Top


Helicobacter pylori is a Gram-negative spiral microaerophilic bacterium that widely (up to 50%) colonises the human gastric epithelium worldwide.[1] It is recognised as a major aetiology of many pathological conditions, including gastritis, peptic ulcer, gastric carcinoma (GC) and mucosa-associated lymphoid tissue lymphoma.[2] Besides its unique ability to overcome the gastric acidity, its high motility and its ability of cytotoxins production, H. pylori possess many factors that appear to reduce the inflammation and evade the host immune response.[3] In addition to the bacterial and the environmental factors, host genetic polymorphisms related to the innate and adaptive immune systems have been proposed as possible predictors of H. pylori infection clinical outcomes.[4]H. pylori infection is followed by neutrophils and mononuclear cells activation with the production of both pro-inflammatory and anti-inflammatory cytokines.[5] Polymorphisms among genes that influence immune cell activation and/or cytokine production may cause disequilibrium between aggressive and protective factors acting in the host's mucosa and hence influence the individual's clinical outcome.[3] Toll-like receptors (TLRs) belong to a large family called pattern recognition receptors (PRRs). In humans, ten TLRs have been well identified on the surfaces of immune-competent cells as well as other cells, including gastric epithelial cells.[6],[7] TLRs are expressed in Type I transmembrane proteins pattern, and their recognition results in activation of nuclear factor-kappa β (NF-κβ), induction of cytokines production and expression of antigen-presenting molecules.[8] These signalling cascades induce several co-stimulatory molecules essential for adaptive immune responses.[9] TLRs can recognise different microbial components; surface components as lipopolysaccharides (LPS) and lipoproteins could be recognised by TLR1, 2, 4, 5 and 6, while microbial nucleic acids could be recognised by TLR3, 7, 8 and 9.[10],[11],[12] Furthermore, TLR10 is expressed on the surface gastric epithelial cells and involved in recognition of multiple distinct patterns of H. pylori LPS.[3] Previous studies have demonstrated the role of TLRs along with interleukins (ILs), chemokines and adhesion molecules in the mucosal immune response against H. pylori infection. The studies revealed that the gastric epithelial cells TLRs expression was higher in H. pylori-infected than non-infected gastric mucosa.[13],[14],[15] Furthermore, in the late stages of H. pylori infection, the intense expressions of TLRs likely activate pro-oncogenes leading to epithelial dysplasia and adenocarcinoma.[16] Although H. pylori infection constitutes a major risk factor for gastric malignancy, only 1%–2% of the H. pylori-infected individuals develop gastric cancer. H. pylori infection outcomes, including malignancy, are related to many bacterial and host genetic factors.[17] A previous European study has revealed an association between TLRs genetic variation and H. pylori prevalence rate, indicating that these polymorphisms might play a role in modulation of the host immune response and the susceptibility to H. pylori infection.[18] Furthermore, recent studies revealed a significant association between the presence of single-nucleotide polymorphisms (SNPs) of TLRs and gastric cancer development. These SNPs might enable H. pylori for a prolonged infection, subsequently, may lead to chronic inflammation and carcinogenesis.[19],[20],[21] However, the association between SNPs of TLRs and H. pylori infection's outcomes is still controversial among different ethnic populations. To the best of our knowledge, the impact of TLRs polymorphisms on the H. pylori-related gastric diseases has not yet been investigated in Saudi Arabia. Hence, the investigation of these polymorphisms may provide novel insights to improve the management of H. pylori-related gasteropathies among the Saudi population. The aim of this work was to investigate the association of the common SNPs in TLR2, 4, 9 and 10 with H. pylori-related gastric diseases among Saudi patients.


 ~ Materials and Methods Top


Study design and population

This is a case-control study that was conducted during the period from April 2017 to September 2019. The study was approved by the Research Ethics Committee at Taif University. All participants were oriented about the study, and written consent was obtained from every patient. Two hundred and ninety patients were selected from the distinct public and private hospitals in the Taif region, Saudi Arabia. The patients were undergoing gastroscopy to investigate for upper gastrointestinal complaints related to H. pylori diseases (defined according to the Rome IV criteria).[22] According to the endoscopic findings and histopathological diagnosis, patients were retrospectively categorised into three groups; Group 1 (90 patients) diagnosed with chronic gastritis, Group 2 (75 patients) diagnosed as peptic ulcer disease (PUD) and Group 3 (45 patients) diagnosed with GC. In addition to H. pylori-negative control group (80 patients). Data regarding medical history, physical examination and endoscopic findings were recorded. Patients with a recent history (within the last 4 weeks) of anti-H. pylori eradication therapy were excluded from the study.

Biopsy specimens and diagnosis of Helicobacter pylori

From each patient, two biopsies were collected from the gastric antrum and body. The biopsies were examined by a rapid urease test (RUT) (Pylori Tek, Serim Research, Elkhart, Indiana, US) to screen for H. pylori infection. Molecular confirmation to determine the final H. pylori positive status was done by GenoType HelicoDR testing (Hain Life Science GmbH, Nehren, Germany). H. pylori-negative biopsies (based on both RUT and GenoType HelicoDR test) from 80 patients without significant endoscopic findings were also collected as controls.

DNA preparation

Genomic DNA was extracted from the gastric formalin-fixed paraffin-embedded (FFPE) biopsies using QIAamp DNA FFPE Tissue Kit (Qiagen, Santa Clara, CA) according to the manufacturer's instructions. The extracted DNA was stored at −20°C for genotyping assays of the six common SNPs in TLR2, TLR4, TLR9 and TLR10 genes that had been reported with functional effects or association with H. pylori infection outcome.[20],[21],[23],[24],[25]

Genotyping of toll-like receptors gene polymorphisms

TLR2 (rs3804099 and rs3804100) and TLR10-rs10004195 SNPs were determined by TaqMan allelic discrimination genotyping assay (Applied Biosystems, Waltham, Massachusetts, US). Real-time polymerase chain reaction (PCR) was performed according to the manufacturer's instructions by Light Cycler 480 II instrument (Roche Diagnostics, Indianapolis, Indiana, US) as described before.[26] Briefly, the PCR conditions were as follows: the initial cycle of 95°C for 10 min, followed by 55 cycles of 95°C for 15 s, and final extension at 60°C for 1 min. TLR4 (rs4986790 and rs4986791) and TLR9-rs352140 SNPs were investigated by restriction fragment length polymorphism (PCR-RFLP). TLR4 SNPs were determined as described by Michel et al.[26] Briefly, initial cycle at 94°C for 10 min, 35 cycles at 94°C for 30 s, 61°C for 40 s (59°C in case of rs4986791), then final extension at 72°C for 10 min. PCR products were digested by restriction enzymes and then were electrophoresed in a 12% polyacrylamide gel. TLR9-rs352140 SNP was genotyped through PCR-RFLP as described by Loganathan et al.[23] The primers sequences, restriction enzymes and restriction fragments of wild-type and mutant alleles are shown in [Table 1].
Table 1: The primers sequences, restriction enzymes and fragment size of toll-like receptor 4 and toll-like receptor 9 polymerase chain reaction-restriction fragment length polymorphism analysis

Click here to view


Statistical analysis

Statistical analysis was performed using SPSS, version 22 (SPSS Inc., Chicago IL, USA), genotype frequencies were directly counted. The genotype distribution in H. pylori-infected patients and the controls were analysed using Chi-square test or Fisher exact test, where appropriate. Genotypes which were statistically significant by univariate analysis were further analysed by logistic regression to reveal the most important predictor genotype. Genotype frequencies were tested by Hardy-Weinberg equilibrium law. A statistical significance was considered when the P < 0.05.


 ~ Results Top


Patients' characteristics

A total of 290 patients were included in this study, 117 males and 93 females. H. pylori infection was confirmed in 210 patients; 90 patients were diagnosed with chronic gastritis (Group 1), 75 patients were diagnosed with PUD (Group 2) and 45 patients were diagnosed with GC (Group 3). In addition to 80 H. pylori-negative subjects with no significant endoscopic or pathological findings were selected as controls. Other patients' characteristics are summarised in [Table 2]. No significant statistical differences were observed between H. pylori-positive patients and control group regarding age, sex, smoking or alcohol consumption.
Table 2: The demographic and clinical characteristics of the study population

Click here to view


Association between toll-like receptors single nucleotide polymorphisms and Helicobacter pylori infection

The genotypes and alleles frequencies of the studied six SNPs are shown in [Table 3] and [Table 4]. The distributions of each of the six SNPs were tested by goodness-of-fit test for their deviation from expected values. According to Hardy-Weinberg equilibrium law; all SNPs fitted the HWE except for TLR2-rs3804099 and that was excluded from later analysis. The distribution of TLR2-rs3804100 showed higher frequencies of the TT genotype than the TC/CC genotypes. However, no significant statistical difference was observed between H. pylori infected patients and the controls [Table 3]. Furthermore, the differences were statistically insignificant when comparing each patient group with the controls [Table 4]. Both TLR4-rs4986790 and-rs4986791 SNPs showed significant difference (odds ratio [OR] = 4.28, 95% confidence interval [CI] = 1.27–14.44, P = 0.009 and OR = 3.47, 95% CI = 1.02–11.83, P = 0.023, respectively) in genotypes distribution between H. pylori-infected patients and the controls [Table 3]. However, this significant difference is restricted to patients with chronic gastritis (OR = 4.33, 95% CI = 1.19–15.81, P = 0.013 and OR = 6.2, 95% CI = 1.64–12.13, P = 0.004, respectively) and GC (OR = 3.57, 95% CI = 0.96–13.31, P = 0.029 and OR = 3.95, 95% CI = 0.94–16.64, P = 0.031, respectively). While, the difference was non-significant between patients with PUD and controls [Table 4]. The distribution of TLR9-rs352140 genotypes showed no significant association with the overall H. pylori infection status (P > 0.5). However, TLR9-rs352140 TT genotype was found significantly higher among chronic gastritis patients compared to the control group (OR = 2.87, 95% CI = 1.07–7.69, P = 0.018). The distribution of TLR10-rs10004195 SNP showed significant association with the H. pylori infection status (OR = 0.50, 95% CI = 0.25–0.99, P = 0.023), especially in patients with chronic gastritis and PUD (OR = 0.26, 95% CI = 0.10–0.71, P = 0.004 and OR = 0.26, 95% CI = 0.09–0.76, P = 0.007 respectively) [Table 3] and [Table 4]. TLR4 and TLR10 SNPs which were statistically significant by univariate analysis were further analysed by logistic regression to reveal the most important predictor genotype. Logistic regression revealed that the only significant SNP predictor for the disease was TLR10-rs10004195 (P < 0.001, wald 21.6).
Table 3: The association between toll-like receptors genotypes and alleles with Helicobacter pylori infection status

Click here to view
Table 4: Association between toll-like receptors genotypes and alleles with the clinical outcome of Helicobacter pylori infection

Click here to view



 ~ Discussion Top


The outcome of H. pylori infection is supposed to be regulated by three main factors; bacterial virulence constituents, host immunity and genetic susceptibility in addition to gastric environmental factors.[7] The host's innate immunity is the first line of defence against the invading pathogens.[27] In the case of H. pylori, gastric epithelial cells are considered the first line of innate immunity against infection.[28] The Gastric epithelial cells were found to express pattern recognition receptors (PRRs) as TLRs. These TLRs can recognise different bacterial components and trigger many cell signalling cascades playing an essential role in the recruitment of adaptive immunity and host's inflammatory response.[10] Recent studies have investigated TLRs genetic polymorphisms and the possible link with H. pylor i-associated gasteropathies.[6] TLR2 is one of the best characterised TLRs. It can recognise bacterial LPS, lipoproteins and peptidoglycan resulting in the production of several pro-inflammatory cytokines and initiation of Th1 immune response.[11],[29] Several studies reported an increase of TLR2 expression in gastric mucosa as a result of H. pylori infection as well as in H. pylori-associated GC.[30],[31] In the present study, two common TLR2 SNPs were investigated; TLR2-rs3804099 and TLR2-rs3804100. The results failed to identify any significant association between either of these two SNPs and H. pylori infection or H. pylori-associated gastric diseases. These results are consistent with two previous studies conducted in Japanese and Thai patients.[26],[32] Contrariwise, many previous studies reported significant association between these SNPs and H. pylori infection and its sequels, especially GC.[33],[34] In humans, TLR4 was the first identified receptor out of all TLRs. Alongside TLR2, TLR4 can recognise bacterial LPS and activate both innate and adaptive immunity through NF-κβ pathway in gastric epithelial cells.[6] TLR4 expression was found to be up-regulated at the apical and basolateral membrane of gastric epithelial cells as a result of H. pylori infection.[30] Therefore, gene polymorphisms that resulted in hypo-reactive or reduced functioning TLR4 may be associated with a reduced immune response, eventually lead to a persistent infection.[35] In this studyTLR4-rs4986790 and TLR4-rs4986791 were investigated. Both SNPs had a significant association with H. pylori infection [Table 3]. However, this association was insignificant among the PUD group compared to the controls [Table 4]. These results were concordant with the earlier studies in different ethnic populations in whom these TLR4 gene polymorphisms were associated with susceptibility to H. pylori infection.[6],[19],[23],[34],[36] On the other hand, other studies revealed no significant association between TLR4 polymorphisms and H. pylori infection or its long term consequences.[32],[37] A probable explanation for this association was reported by Uno et al.,[6] where, TLR4-rs4986790 GG genotype gene variant may functionally diminish the TLR4 binding affinity to H. pylori LPS resulting in a diminished the adaptive immune response offered by wild type TLR4 with subsequent development of chronic inflammation and carcinogenesis. Furthermore, Moura et al.,[38] have reported an interesting observation where these TLR4 gene variants were significantly associated with infection by the more virulent H. pylori CagA-positive strains. Therefore, the wild-type TLR4 may be considered as an inhibitor of these virulent H. pylori strains.[7] TLR9 is an endosome-trans-membrane receptor that able to recognise microbial DNA.[39] On H. pylori DNA recognition by TLR9, either pro-inflammatory or anti-inflammatory responses may be induced. This dichotomous role of TLR9 in the case of H. pylori infection is highly influenced by the gastric microenvironment. The anti-inflammatory responses were recorded mainly during the acute phase that enable H. pylori to establish persistent infection.[7],[40] The results of the current study showed a significant association between TLR9-rs352140 SNP and H. pylori-associated chronic gastritis, which mean that the occurrence of this SNP may potentiate the anti-inflammatory response and increase the incidence of chronic gastritis. This conclusion is consistent with many earlier studies.[41],[42] On the contrary, Zhao et al.[34] reported no significant association between TLR9 SNP and H. pylori-related diseases. However, further studies are still required to identify precisely micro-environmental conditions that trigger either the pro-inflammatory or the anti-inflammatory response by TLR9.[43] TLR10 is expressed on the surface gastric epithelial cells forming heterodimers with TLR2 and/or TLR6. These heterodimers recognise multiple distinct patterns of H. pylori LPS and diversify innate immune recognition.[3],[44] Few studies have investigated TLR10 SNP association with H. pylori-related gastric pathology. This study indicated that TLR10-rs10004195 was identified to be significantly associated with the susceptibility to H. pylori infection where the rate of variant TT genotype and T allele were found to be significantly lower among both of chronic H. pylori infection and PUD groups compared to the controls. These results are consistent with a previous study conducted in the European population.[18] Furthermore, Tang et al.,[45] reported that rs10004195 T allele was significantly associated with a decreased risk of H. pylori infection and atrophic gastritis among the Chinese population. This difference in the inflammatory response and outcomes may be mediated by a modulation of the signalling pathway that leads to the downstream expression of the inflammatory cytokines as IL-1 β, IL-1α, IL-6, IL-8, IL-10, and tumor necrosis factor alpha.[46] On the other hand, TLR10-rs10004195 T allele showed no significant protective effect against H. pylori infection or its long-term consequences in Malaysian patients.[24] That statistical analysis of the distribution of the studied TLR SNPs among the different H. pylori infection outcomes revealed that TLR4 SNPs showed no significant differences in the distribution among PUD and GC patients compared to chronic gastritis group. While TLR9 TT genotype was found to be significantly less prevalent among PUD and GC patients compared to the chronic gastritis group (P = 0.007 and 0.018, respectively). Furthermore, TLR10 TT genotype was found to be significantly more prevalent among GC patients compared to the chronic gastritis group (P = 0.003).

Conclusion

The results of the present study revealed more association between TLR SNPs and chronic gastritis, whether increasing its risk (in case of TLR4 and TLR9) or provide a protective effect (in case of TLR10) while PUD had the lowest association with these SNPs. It seems that TLR SNPs may affect H. pylori infection susceptibility and its outcome. However, many other factors should be considered, especially the ethnic factors that may modify this effect. Furthermore, these results should be cautiously interpreted, and further studies performed on a larger scale are needed for confirmation of the relationship of these TLRs SNPs with the H. pylori infection susceptibility and its long-term consequences. However, the awareness about the predominant hosts' TLRs genotypes in a certain region may enable better prediction of H. pylori infection outcomes among those population.

Financial support and sponsorship

This study was funded by the Deanship of Scientific Research, Taif University, KSA (project number 1-439-6081).

Conflicts of interest

There are no conflicts of interest.



 
 ~ References Top

1.
Venneman K, Huybrechts I, Gunter MJ, Vandendaele L, Herrero R, Van Herck K. The epidemiology of Helicobacter pylori infection in Europe and the impact of lifestyle on its natural evolution toward stomach cancer after infection: A systematic review. Helicobacter 2018;23:e12483.  Back to cited text no. 1
    
2.
Eed EM, Hawash YA, Khalifa AS, Alsharif KF, Alghamdi SA, Saber T, et al. Molecular diagnosis of Helicobacter pylori antibiotic resistance in the Taif region, Saudi Arabia. Microbiol Immunol 2019;63:199-205.  Back to cited text no. 2
    
3.
Miftahussurur M, Yamaoka Y. Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease. Expert Rev Gastroenterol Hepatol 2015;9:1535-47.  Back to cited text no. 3
    
4.
Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 2002;123:414-24.  Back to cited text no. 4
    
5.
Hwang IR, Kodama T, Kikuchi S. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin1 beta production in Helicobacter pylori infection. Gastroenterology 2002;123:1793-803.  Back to cited text no. 5
    
6.
Uno K, Kato K, Shimosegawa T. Novel role of toll-like receptors in Helicobacter pylori- induced gastric malignancy. World J Gastroenterol 2014;20:5244-51.  Back to cited text no. 6
    
7.
Meliţ LE, Mărginean CO, Mărginean CD, Mărginean MO. The relationship between toll-like receptors and Helicobacter pylori-related gastropathies: Still a controversial topic. J Immunol Res 2019;2019:8197048.  Back to cited text no. 7
    
8.
O'Neill LA, Golenbock D, Bowie AG. The history of Toll-like receptors - redefining innate immunity. Nat Rev Immunol 2013;13:453-60.  Back to cited text no. 8
    
9.
Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-95.  Back to cited text no. 9
    
10.
Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011;34:637-50.  Back to cited text no. 10
    
11.
Castaño-Rodríguez N, Kaakoush NO, Pardo AL, Goh KL, Fock KM, Mitchell HM. Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer. Hum Immunol 2014;75:808-15.  Back to cited text no. 11
    
12.
Varga MG, Shaffer CL, Sierra JC, Suarez G, Piazuelo MB, Whitaker ME, et al. Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system. Oncogene 2016;35:6262-9.  Back to cited text no. 12
    
13.
Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Müller-Hermelink HK, et al. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004;136:521-6.  Back to cited text no. 13
    
14.
Su B, Ceponis PJ, Lebel S, Huynh H, Sherman PM. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun 2003;71:3496-502.  Back to cited text no. 14
    
15.
Ishihara S, Rumi MA, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N, et al. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 2004;173:1406-16.  Back to cited text no. 15
    
16.
Pimentel-Nunes P, Gonçalves N, Boal-Carvalho I, Afonso L, Lopes P, Roncon-Albuquerque R Jr., et al. Helicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis. Helicobacter 2013;18:22-32.  Back to cited text no. 16
    
17.
Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 2009;15:971-6.  Back to cited text no. 17
    
18.
Mayerle J, den Hoed CM, Schurmann C, Stolk L, Homuth G, Peters MJ, et al. Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA 2013;309:1912-20.  Back to cited text no. 18
    
19.
de Oliveira JG, Silva AE. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population. World J Gastroenterol 2012;18:1235-42.  Back to cited text no. 19
    
20.
Santini D, Angeletti S, Ruzzo A, Dicuonzo G, Galluzzo S, Vincenzi B, et al. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes. Clin Exp Immunol 2008;154:360-4.  Back to cited text no. 20
    
21.
Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, Flores-Gutierrez JP, Maldonado-Garza HJ, Perez-Perez GI. Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 2007;7:70.  Back to cited text no. 21
    
22.
Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil 2017;23:151-63.  Back to cited text no. 22
    
23.
Loganathan R, Nazeer M, Goda V, Devaraju P, Ali M, Karunakaran P, et al. Genetic variants of TLR4 and TLR9 are risk factors for chronic Helicobacter pylori infection in South Indian Tamils. Hum Immunol 2017;78:216-20.  Back to cited text no. 23
    
24.
Ravishankar Ram M, Goh KL, Leow AH, Poh BH, Loke MF, Harrison R, et al. Polymorphisms at locus 4p14 of toll-like receptors TLR-1 and TLR-10 confer susceptibility to gastric carcinoma in Helicobacter pylori infection. PLoS One 2015;10:e0141865.  Back to cited text no. 24
    
25.
Tourani M, Habibzadeh M, Shokri-Shirvani J, Teymournejad O, Mostafazadeh A, Khafri S, et al. Association of Helicobacter pylori infection with Toll-like receptor-4 Thr399Ile polymorphism increased the risk of peptic ulcer development in North of Iran. APMIS 2018;126:76-84.  Back to cited text no. 25
    
26.
Tongtawee T, Bartpho T, Kaewpitoon S, Kaewpitoon N, Dechsukhum C, Leeanansaksiri W, et al. Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis: A prospective cross-sectional study in Thailand. Eur J Cancer Prev 2018;27:118-23.  Back to cited text no. 26
    
27.
Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009;21:317-37.  Back to cited text no. 27
    
28.
Mandell L, Moran AP, Cocchiarella A. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via Toll-like receptor 2 but not Toll-like receptor 4. Infect Immun 2004;72:6446-54.  Back to cited text no. 28
    
29.
Smith SM, Moran AP, Duggan SP, Ahmed SE, Mohamed AS, Windle HJ, et al. Tribbles 3: A novel regulator of TLR2-mediated signaling in response to Helicobacter pylori lipopolysaccharide. J Immunol 2011;186:2462-71.  Back to cited text no. 29
    
30.
Uno K, Kato K, Atsumi T. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007;293:1004-12.  Back to cited text no. 30
    
31.
Khakzad MR, Saffari A, Mohamadpour N, Sankian M, Varasteh A, Salari F, et al. TLR4 and TLR2 expression in biopsy specimens from antral and corporal stomach zones in Helicobacter pylori infections. Rep Biochem Mol Biol 2014;3:29-37.  Back to cited text no. 31
    
32.
Hishida A, Matsuo K, Goto Y, Mitsuda Y, Hiraki A, Naito M, et al. Toll-like receptor 4+3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Helicobacter 2009;14:47-53.  Back to cited text no. 32
    
33.
Zhao D, Wu YH, Zhao TC, Jia ZF, Cao DH, Yang N, et al. Single-nucleotide polymorphisms in Toll-like receptor genes are associated with the prognosis of gastric cancer and are not associated with Helicobacter pylori infection. Infect Genet Evol 2019;73:384-9.  Back to cited text no. 33
    
34.
Castaño-Rodríguez N, Kaakoush NO, Goh KL, Fock KM, Mitchell HM. The role of TLR2, TLR4 and CD14 genetic polymorphisms in gastric carcinogenesis: A case-control study and meta-analysis. PLoS One 2013;8:e60327.  Back to cited text no. 34
    
35.
Faber J, Meyer CU, Gemmer C, Russo A, Finn A, Murdoch C, et al. Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy. Pediatr Infect Dis J 2006;25:80-1.  Back to cited text no. 35
    
36.
Fan YF, Wu YM, Liu H, Yu Y, Jiang YY, Xue YZ, et al. TLR4 polymorphisms associated with developing gastric pre-cancer lesions in a Chinese Han population. Hum Immunol 2014;75:176-81.  Back to cited text no. 36
    
37.
Kupcinskas J, Wex T, Bornschein J, Selgrad M, Leja M, Juozaityte E, et al. Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians. BMC Med Genet 2011;12:112.  Back to cited text no. 37
    
38.
Moura SB, Almeida LR, Guerra JB, Rocha GA, Camargos Rocha AM, Melo FF, et al. Toll-like receptor (TLR2, TLR4 and TLR5) gene polymorphisms and Helicobacter pylori infection in children with and without duodenal ulcer. Microbes Infect 2008;10:1477-83.  Back to cited text no. 38
    
39.
Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-5.  Back to cited text no. 39
    
40.
Rad R, Ballhorn W, Voland P, Eisenächer K, Mages J, Rad L, et al. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. Gastroenterology 2009;136:2247-57.  Back to cited text no. 40
    
41.
Roszak A, Lianeri M, Sowin A, Jagodzin PP. Involvement of Toll-like receptor 9 polymorphism in cervical cancer development. Mol Biol Rep 2012;39:8425-30.  Back to cited text no. 41
    
42.
Zhang L, Qin H, Guan X, Zhang K, Liu Z. The TLR9 gene polymorphisms and the risk of cancer: Evidence from a meta-analysis. PLoS One 2013;8:e71785.  Back to cited text no. 42
    
43.
Trejo OA, Torres J, Sanchez-Zauco N. Polymorphisms in TLR9 but not in TLR5 increase the risk for duodenal ulcer and alter cytokine expression in the gastric mucosa. Innate Immun 2015;21:706-13.  Back to cited text no. 43
    
44.
Tongtawee T, Bartpho T, Wattanawongdon W, Dechsukhum C, Leeanansaksiri W, Matrakool L, et al. Role of toll-like receptor 10 gene polymorphism and gastric mucosal pattern in patients with chronic gastritis. Turk J Gastroenterol 2017;28:243-7.  Back to cited text no. 44
    
45.
Tang FB, Li ZX, Wang YM, Zhang L, Ma JL, Zhou T, et al. Toll-like receptor 1 and 10 polymorphisms, Helicobacter pylori susceptibility and risk of gastric lesions in a high-risk Chinese population. Infect Genet Evol 2015;31:263-9.  Back to cited text no. 45
    
46.
Michel O, LeVan TD, Stern D, Dentener M, Thorn J, Gnat D, et al. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. J Allergy Clin Immunol 2003;112:923-9.  Back to cited text no. 46
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
Print this article  Email this article
 

    

2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04